Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC2 | Q92769 | 3/20 | 0.57 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.57 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.57 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.50 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | CTSK | P43235 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.48 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.48 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14827239 | 0.98 | HDAC4 (0.55) | HDAC2HDAC4HDAC8HDAC6CHRM3 | |
| SCHEMBL15426911 | 0.98 | HDAC4 (0.55) | HDAC2HDAC4HDAC8HDAC6CHRM3 | |
| SCHEMBL15426906 | 0.98 | HDAC4 (0.55) | HDAC2HDAC4HDAC8HDAC6CHRM3 | |
| SCHEMBL11371613 | 0.98 | HDAC4 (0.55) | HDAC2HDAC4HDAC8HDAC6CHRM3 | |
| SCHEMBL11326897 | 0.98 | HDAC4 (0.55) | HDAC2HDAC4HDAC8HDAC6CHRM3 | |
| SCHEMBL4710137 | 0.98 | HDAC4 (0.55) | HDAC2HDAC4HDAC8HDAC6CHRM3 | |
| SCHEMBL11323894 | 0.98 | HDAC4 (0.55) | HDAC2HDAC4HDAC8HDAC6CHRM3 | |
| SCHEMBL9806702 | 0.98 | HDAC4 (0.55) | HDAC2HDAC4HDAC8HDAC6CHRM3 | |
| SCHEMBL9806700 | 0.98 | HDAC4 (0.55) | HDAC2HDAC4HDAC8HDAC6CHRM3 | |
| SCHEMBL11371607 | 0.98 | HDAC4 (0.55) | HDAC2HDAC4HDAC8HDAC6CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 265 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2976400-B1 | ZUSAMMENSETZUNG, ENTHALTEND ALLOPHANATE | VENCOREX FRANCE (FR) | 2024-07-24 | — | — | EP | claimed |
| EP-4332124-A1 | METHYL METHACRYLATE-CONTAINING COMPOSITION AND METHYL METHACRYLATE POLYMER PRODUCTION METHOD | Mitsubishi Chemical Corporation (JP) | 2024-03-06 | — | — | EP | claimed |
| US-20240059818-A1 | METHYL METHACRYLATE-CONTAINING COMPOSITION AND METHYL METHACRYLATE POLYMER PRODUCTION METHOD | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-02-22 | — | — | US | claimed |
| CN-117242103-A | Methyl methacrylate-containing composition and method for producing methyl methacrylate polymer | 三菱化学株式会社 | 2023-12-15 | — | — | CN | claimed |
| WO-2022230913-A1 | METHYL METHACRYLATE-CONTAINING COMPOSITION AND METHYL METHACRYLATE POLYMER PRODUCTION METHOD | 三菱ケミカル株式会社 | 2022-11-03 | — | — | WO | claimed |
| CN-109761810-B | Preparation method of inactive alkene aryl compound | 浙江工业大学 | 2021-07-27 | — | — | CN | claimed |
| CN-106588525-A | Method for synthesizing ph-dicarbonyl-aryl-formic-ether series compounds based on metal-free participation method | 嘉兴学院 | 2017-04-26 | — | — | CN | claimed |
| EP-1363952-B1 | METHOD FOR OBTAINING A STABILISED PHOTOCHROMIC LATEX, LATEX OBTAINED AND USE IN OPHTHALMIC OPTICS | ESSILOR INT (FR) | 2005-07-27 | — | — | EP | claimed |
| US-6740699-B2 | EMULSION POLYMERIZATION OF CYCLOHEXENE-STABILIZED SOLUTION OF METHALLYL ALCOHOL; PHOTOSTABILITY | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) | 2004-05-25 | — | — | US | claimed |
| US-20030100672-A1 | Method for obtaining a stabilized photochromic latex, latex obtained, and application to ophthalmic optics | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE | 2003-05-29 | — | — | US | claimed |
| WO-2025224168-A1 | ARYL SULFONE AND SULFANONE DERIVATIVES AS OREXIN RECEPTOR MODULATORS | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-10-30 | — | — | WO | disclosed |
| EP-4613784-A1 | ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME | Mitsubishi Chemical Corporation (JP) | 2025-09-10 | — | — | EP | disclosed |
| US-20250250223-A1 | ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-08-07 | — | — | US | disclosed |
| WO-2025124698-A1 | ARYL SULFONE AND SULFANONE DERIVATIVES AS OREXIN RECEPTOR MODULATORS | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-06-19 | — | — | WO | disclosed |
| CN-120118001-A | Aerobic nitriding method for olefin compounds | 北京大学 | 2025-06-10 | — | — | CN | disclosed |
| EP-0135142-A2 | Cephalosporin derivatives and process for their preparation | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-03-27 | — | — | EP | disclosed |
| EP-0111934-A2 | Cephalosporin derivatives and process for their preparation | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-06-27 | — | — | EP | disclosed |
| EP-0088320-A2 | Cephalosporin derivatives and process for their preparation | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-09-14 | — | — | EP | disclosed |
| EP-0064740-A2 | Cephalosporin derivatives, and process for their preparation | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-11-17 | — | — | EP | disclosed |
| US-4249015-A | Preparation of organic acids and/or esters | SHELL OIL COMPANY (US) | 1981-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250250223-A1 | ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME | MMAB, ADCY8, MAT1A | HDAC2 2887/4885HDAC4 3011/4885HDAC8 845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.